Metsera (NASDAQ:MTSR), headquartered in Centennial, Colorado, is a medical technology company specializing in the design and manufacture of fluid filtration and purification systems. Founded in 2010, the firm originally focused on developing inline ultrafiltration solutions for dialysis applications and later rebranded as Metsera in 2020 following a strategic merger. Through this evolution, the company has established itself as a provider of high-purity filtration components that enhance the safety and efficacy of critical fluid pathways in healthcare and life sciences.
At the core of Metsera’s product portfolio is its AISTR® (Automatic Inline Sterile Delivery) ultrafilter, engineered to remove bacteria, endotoxins and submicron particulates from fluid streams. In addition to its flagship ultrafilter cartridge, the company offers custom-engineered filtration modules, disposable fluid pathway assemblies and validation services to support rigorous regulatory requirements. These solutions are utilized in renal care, biotechnology manufacturing, laboratory instrumentation and other applications where fluid purity is paramount.
Metsera serves a global customer base that includes original equipment manufacturers (OEMs), healthcare systems and contract manufacturing organizations across North America, Europe and the Asia-Pacific region. The company holds ISO 13485 certification and CE marking, facilitating access to regulated markets worldwide. By forging strategic distribution partnerships and maintaining dedicated technical support teams, Metsera has expanded its presence to more than 25 countries and continues to drive adoption of its filtration technologies among leading medical device and life sciences firms.
Led by a management team with extensive experience in medical device development, regulatory affairs and global commercialization, Metsera places a strong emphasis on research and development to enhance product performance and production scalability. The executive leadership draws on backgrounds at major healthcare and life sciences companies, combining deep technical expertise with commercial acumen. Looking ahead, Metsera plans to advance next-generation filtration systems, pursue collaborative OEM engagements and explore targeted acquisitions to accelerate its growth trajectory in high-purity fluid management.
